About Gaize
Gaize is an advanced impairment detection platform that uses high-precision sensors and machine learning to identify active intoxication from various substances, including cannabis, alcohol, opiates, and stimulants. Unlike traditional drug tests that measure metabolites in biological fluids—often indicating past use rather than current impairment—Gaize focuses on physiological indicators through automated ocular examinations. By utilizing a specialized headset to capture eye movement, pupil size, and head motion, the system provides an objective, real-time assessment of whether an individual is fit for duty.
The technology operates by digitizing well-established Drug Recognition Expert (DRE) protocols used by law enforcement for decades. When a user wears the headset, the device performs a series of automated eye tests over a six-minute period. These tests are analyzed by proprietary machine learning and statistical models to detect micro-movements and reactions that signify impairment. Because the process is fully automated, it removes the need for human expertise or subjective interpretation during the test, delivering results instantly to a mobile or web-based dashboard for immediate decision-making.
This tool is specifically designed for safety-sensitive industries such as construction, maritime, manufacturing, and transportation, as well as law enforcement agencies. For businesses, it serves as a fair alternative to urinalysis, which can penalize employees for responsible off-duty cannabis use. By focusing on active impairment, employers can maintain high safety standards without losing valuable staff members to outdated testing methods. It also functions as a deterrent, encouraging employees to arrive at work sober while providing defensible, video-recorded evidence of impairment should an incident occur.
What distinguishes Gaize from traditional chemical testing is its speed, hygiene, and focus on current status. It requires no bodily fluids and provides results 99% faster than lab-based tests. The platform is legally defensible in 50 states and offers a significant return on investment by reducing the costs associated with lab confirmations and downtime. By combining 45 years of ocular science with modern AI, Gaize offers a high-accuracy solution that bridges the gap between workforce safety requirements and the shifting landscape of cannabis legalization.
Gaize FAQs
What substances can Gaize detect?
Gaize detects impairment from a broad spectrum of substances including marijuana, alcohol, opiates like fentanyl, stimulants, psychedelics, and dissociative anesthetics.
Is the test legally defensible for workplace use?
Yes, it is designed to be legal in all 50 states and uses automated versions of eye tests that have been used by law enforcement for over 45 years.
How long does it take to get results?
The entire automated testing process takes approximately 6 minutes, with results generated and available for review in real-time.
Does it require biological samples?
No, the system is non-invasive and requires no blood, urine, or saliva; it only captures ocular data and video evidence via a specialized headset.
How accurate is the system?
The platform is over 98% accurate at detecting the signs of impairment for each drug category, making it more reliable than many traditional drug tests.